News

November 17 RFL Briefing with The Hill on Genetic Testing in Cancer Care

Results for Life and the American Clinical Laboratory Association in conjunction with The Hill newspaper hosted a Congressional briefing November 17 on "The Innovation Revolution: Genetic Testing in Today's Cancer Care". The session focused on how the rapid innovation in genetic testing is resulting in significant advances in a range of cancer care, including leukemia, colon cancer, and breast cancer.

Rep. Michael Burgess, MD (R-TX), Vice Chairman of the House Ways and Means Health Subcommittee, and Rep. Charlie Gonzalez (D-TX) opened the session, as they did a similar RFL session in March. Other speakers included Mara Bloom, Executive Director, Massachusetts General Hospital Cancer Center; Bill McGivney, CEO, National Comprehensive Cancer Network; Marc Grodman, MD, President, CEO, and Chairman of the Board, Bio-Reference Laboratories, Inc.; and Simon Tripp, Senior Director, Battelle Memorial Institute.

Click here to watch briefing on YouTube

Click here to watch briefing video

Twitter hash tag: #genetestbriefing

Click here for agenda

Click here for Mara Bloom slides

Click here for Bill McGivney slides

Click here for Simon Tripp slides

Click here for briefing media release

Click here for genetic testing backgrounder: "A New Tool to Tailor Treatment, Reduce Side-effects, and Manage Drug Costs: Genetic Tests Help Physicians Target Medication and Dosage for Cancer Patients"

Click here for briefing invitation

Click here for briefing ad campaign

Click here for RFL storyboard on personalized medicine